Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA.
Numerous recent studies have demonstrated the use of genomic data, particularly gene expression signatures, as clinical prognostic factors in cancer and other complex diseases. These studies highlight the opportunity for strategies to achieve truly personalized cancer treatment. In particular, the ability to develop gene expression signatures will likely allow us to guide the use of currently available cancer drugs, develop new targeted therapeutics, and provide an opportunity to better match the most effective drug or drugs with the molecular characteristics of the individual patient.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on